levoleucovorin

Preferred Label : levoleucovorin;

MeSH definition : A folate analog consisting of the pharmacologically active isomer of LEUCOVORIN.;

MeSH synonym : leucovorin, (S)-Isomer; 6-S-leucovorin; 6 S leucovorin; S-leucovorin; S leucovorin; levo-leucovorin; levo leucovorin; (6S)-leucovorin; 6S-leucovorin; 6S leucovorin;

CISMeF synonym : L-FOLINIC ACID;

MeSH hyponym : fusilev; leucovorin, monopotassium salt, (S)-Isomer; leucovorin, calcium (1:1) salt, (S)-Isomer; leucovorin, monosodium salt, (S)-Isomer;

MeSH Related Number : leucovorin, monosodium salt, (S)-Isomer; leucovorin, monopotassium salt, (S)-Isomer; leucovorin, calcium (1:1) salt, (S)-Isomer; 68538-85-2 (Levoleucovorin); 122291-98-9; 122291-99-0; 80433-71-2;

Registry Number MeSH : 68538-85-2;

Related CAS MeSH : 122291-98-9 (Leucovorin, monosodium salt, (S)-Isomer); 122291-99-0 (Leucovorin, monopotassium salt, (S)-Isomer); 80433-71-2 (Leucovorin, calcium (1:1) salt, (S)-Isomer);

Is substance : O;

UNII : 990S25980Y;

InChIKey : VVIAGPKUTFNRDU-STQMWFEESA-N;

Details

Origin ID

D058766;

UMLS CUI

C2721771;

ATC code(s)
- calcium levofolinate [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- LEVOLEUCOVORIN [SMS substance]
- Levofolinic acid (substance) [SNOMED CT concept]
- Levoleucovorin [NCIt concept]
Pharmacological action(s)
- antidotes [MeSH Descriptor]
Record concept(s)
- fusilev [MeSH concept]
- leucovorin, calcium (1:1) salt, (S)-Isomer [MeSH concept]
- leucovorin, monopotassium salt, (S)-Isomer [MeSH concept]
- leucovorin, monosodium salt, (S)-Isomer [MeSH concept]
- levoleucovorin [MeSH concept]
Related MeSH Supplementary Concept(s)
- ELF protocol [MeSH Supplementary Concept]
- PELF protocol 2 [MeSH Supplementary Concept]
- PFLI-alpha protocol [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Levofolinic acid (substance) [SNOMED CT concept]
- Levoleucovorin [NCIt concept]
- Product containing levofolinic acid (medicinal product) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients